Analyst Asthika Goonewardene works at TRUIST and is focused on the Healthcare sector with 92 price targets and ratings documented since 2020 spanning on 14 stocks. Analyst's average stock valuation to be materialised ratio is 24.88% with an average time for price targets to be met of 81.17 days.
Most recent stock forecast was given on STRO, Sutro Biopharma, Inc at 13-Jan-2023.
Asthika Goonewardene best performing recommendations are on CELU.
The best stock recommendation documented was for ALLO (ALLOGENE THERAPEUTICS, INC) at 4/13/2020. The price target of $29 was fulfilled within 11 days with a profit of $5.58 (23.83%) receiving and performance score of 21.66.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Hold
12
$3.79 (46.16%)
11
29 days ago
1/2 (50%)
$4.3 (64.63%)
18
Buy
9
$0.79 (9.62%)
32
1 months 23 days ago
0/3 (0%)
$9.9 (62.44%)
Buy
18
$9.79 (119.24%)
4 months 13 days ago
0/5 (0%)
$17.14 (114.54%)
Buy
13
5 months 25 days ago
3/5 (60%)
$5.98 (31.80%)
173
Buy
35
$26.79 (326.31%)
40
5 months 25 days ago
2/7 (28.57%)
$16.51 (79.07%)
194
